Plasma levels of histidine-rich glycoprotein (HRG) were investigated i
n three groups of women receiving a different dose of estrogens. First
, the effect of low-dose estrogen was studied in a group of 83 post me
nopausal women who were treated with 0.625 mg conjugated estrogens (CE
). No significant change from baseline levels was found at the end of
cycle 3 and cycle 13. Secondly, in 15 mothers and 23 daughters using o
ral contraceptives (OC) containing 30-50 mu g ethinyl estradiol (EE) d
aily the mean HRG level was 14% and 24% lower than in a group of 144 m
others and 134 daughters not taking oral contraceptives. respectively
(p < 0.05). Finally, in 11 excessively tall prepuberal girls who recei
ved 300 mu g EE daily to reduce their final height the mean plasma HRG
levels were decreased by 68% (p < 0.005). The effect of progestogens
administered during low-dose and high-dose estrogen therapy appeared t
o be minor. The results from these three studies indicate that estroge
ns reduce plasma HRG levels in a dose-dependent way.